Microbix Operating Margin from 2010 to 2026
| MBX Stock | CAD 0.22 0.01 4.35% |
Check Microbix Biosystems financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Microbix Biosystems' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.1 M, Interest Expense of 560.6 K or Selling General Administrative of 11 M, as well as many indicators such as Price To Sales Ratio of 2.17, Dividend Yield of 1.97 or PTB Ratio of 1.45. Microbix financial statements analysis is a perfect complement when working with Microbix Biosystems Valuation or Volatility modules.
Microbix | Operating Margin |
Evaluating Microbix Biosystems's Operating Margin across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Microbix Biosystems's fundamental strength.
Latest Microbix Biosystems' Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Microbix Biosystems over the last few years. It is Microbix Biosystems' Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Microbix Biosystems' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (0.38) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Microbix Operating Margin Regression Statistics
| Arithmetic Mean | (0.01) | |
| Coefficient Of Variation | (1,296) | |
| Mean Deviation | 0.1 | |
| Median | (0.04) | |
| Standard Deviation | 0.13 | |
| Sample Variance | 0.02 | |
| Range | 0.4965 | |
| R-Value | 0.1 | |
| Mean Square Error | 0.02 | |
| R-Squared | 0.01 | |
| Significance | 0.71 | |
| Slope | 0 | |
| Total Sum of Squares | 0.25 |
Microbix Operating Margin History
About Microbix Biosystems Financial Statements
Microbix Biosystems investors utilize fundamental indicators, such as Operating Margin, to predict how Microbix Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Microbix Biosystems Inc., a life science company, manufactures viral and bacterial antigens and reagents for the diagnostics industry worldwide. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada. MICROBIX J is traded on Toronto Stock Exchange in Canada.
Other Information on Investing in Microbix Stock
Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.